<DOC>
	<DOC>NCT01361386</DOC>
	<brief_summary>The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.</brief_summary>
	<brief_title>Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Written informed consent has been provided. Diagnosis of STEMI, NSTEMI or UA Hospitalization for the first time within 48 hours of onset of symptoms. UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or postPCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons. Current participation in a randomised interventional clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Long-term follow up</keyword>
	<keyword>Antithrombotic management patterns</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Asia</keyword>
	<keyword>quality of life</keyword>
</DOC>